Citations

Showing 10 of 108104 citations.

900 mg daily of gabapentin was effective for hot flashes in women with breast cancer
Loprinzi, Charles L.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 144 | Issue: 2 | Pages: 41

10.7326/acpjc-2006-144-2-041 | PMID 16539356 Get It

Evidence-based Medicine Toolkit (2nd edition)
Ghosh, Amit K.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 145 | Issue: 2 | Pages: A11

10.7326/acpjc-2006-145-2-a11 Get It

Review: Magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosis
Weinshenker, Brian G.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 145 | Issue: 2 | Pages: 51

10.7326/acpjc-2006-145-2-051 | PMID 16944871 Get It

Adjunctive inhaled insulin before meals improved glycemic control more than adjunctive metformin in type 2 diabetes mellitus
Kudva, Yogish C. , Basu, Ananda

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 145 | Issue: 3 | Pages: 67

10.7326/acpjc-2006-145-3-067 | PMID 17080979 Get It

Atorvastatin did not prevent cardiovascular events in type 2 diabetes
Montori, Víctor M.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 145 | Issue: 3 | Pages: 62

10.7326/acpjc-2006-145-3-062 | PMID 17080974 Get It

Review: Lifestyle or pharmacologic interventions prevent or delay type 2 diabetes in impaired glucose tolerance
Bhagra, Sumit , Smith, Steven A.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 147 | Issue: 1 | Pages: 1

10.7326/acpjc-2007-147-1-001 | PMID 17608366 Get It

Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factors
Gandhi, Gunjan Y. , Isley, William L.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 146 | Issue: 1 | Pages: 11

10.7326/acpjc-2007-146-1-011 | PMID 17203931 Get It

Ramipril did not reduce incident diabetes in patients with impaired glycemic control
Gandhi, Gunjan Y. , Isley, William L.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 146 | Issue: 1 | Pages: 10

10.7326/acpjc-2007-146-1-010 | PMID 17203930 Get It

Rosiglitazone reduced type 2 diabetes but increased heart failure in patients with impaired glycemic control
Gandhi, Gunjan Y. , Swiglo, Brian A.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 146 | Issue: 1 | Pages: 8

10.7326/acpjc-2007-146-1-008 | PMID 17203928 Get It

Vildagliptin was noninferior to rosiglitazone for glycemic control in type 2 diabetes but caused less weight gain
Montori, Víctor M.

Mayo Clinic

ACP Journal Club | January 18, 2022 | Volume: 146 | Issue: 3 | Pages: 74

10.7326/acpjc-2007-146-3-074 | PMID 17474683 Get It